Ironwood Pharma (NASDAQ: IRWD) reported Q3 EPS of $0.42, $0.29 better than the analyst estimate of $0.13. Revenue for the quarter came in at $96.4 million versus the consensus estimate of $75.9 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

Earnings

Ironwood (IRWD) Updates on Q3 Activity; FDA Approves LINZESS, Linaclotide Gets Nod from CHMPOctober 16, 2012 7:06 AM